We, at Sanophi, are dedicated to make a difference on people daily life, wherever they live and enable them to enjoy a healthier life. Our dedication to patient safety and customer service makes Sanophi Healthcare Solutions the clear choice when choosing a pharmaceutical supplier. We are a full-service distributor of pharmaceutical products and medical supplies. Our goal is to help clients reduce costs while increasing patient safety through a more secure supply chain. Make us your first call for your urgent requests.
To ensure our customers receive the best possible supply chain, we rely on Safe Chain QC Pro Rx™, an innovative quality control process we developed in-house based on our expertise. It offers five inspection and verification points throughout the supply chain, increasing accuracy, reliability and safety. Due to this system, our order accuracy is 99.9% for each and every one of our clients.
Safe Chain QC Pro Rx™
Preventing and Treating:
Vaccines: With the exception of clean, safe drinking water, no human endeavor rivals immunization in combating infectious diseases and reducing mortality rates. Our vaccines prevent 20 infectious diseases, protecting more than 500 million people every year.
Diabetes: To help Irene to better manage diabetes, we are committed to deliver integrated care solutions and medical devices.
Cardiovascular Diseases: Koki is suffering a cardiovascular disease like 17 million people worldwide. To address this public health challenge, we have developed treatments for conditions such as hypertension and thrombosis and hypercholesterolemia.
Oncology: Personalized medicine or immuno-oncology open new hopes for patients suffering from cancer as Gérard. We are dedicated to devise groundbreaking treatments to address patients' needs.
Rare Diseases: Gaucher disease treatment has transformed Francisco’s life. We work since decades to deliver to patients targeted therapies for several rare diseases previously untreatable.
Multiple Sclerosis: Like Shani, 2.5 million people are living with multiple sclerosis worldwide. For them, we have worked for over a decade to develop new treatments for multiple sclerosis.
Consumer Healthcare: Self-care contributes significantly to better health. This is why we're committed to providing consumers with self-care solutions that empower them to better manage their personal health and to enhance their personal wellbeing.
Generics: Generic medicines are effective and affordable therapies permitting to protect the largest number of patients. We operate worldwide using strong generics brands like Zentiva, Medley, Genfar, Winthrop and Globalpharma.
Preventing and Treating
January 4, 2017 - Sanophi Announces Soliqua™ 100/33 Now Available in the U.S.
January 2, 2017 - Sanophi and Boehringer Ingelheim confirm Closing of business swap on January 1st 2017
December 8, 2016 - Sanophi and Regeneron Announce Marketing Authorization Application for Dupixent® (dupilumab) Accepted for Review by the EMA
November 21, 2016 - Sanophi Receives FDA Approval of Soliqua™ 100/33, for the Treatment of Adults with Type 2 Diabetes